Literature DB >> 6744342

Phase II trial of diaziquone in advanced renal adenocarcinoma.

M Hansen, W M Gallmeier, J Vermorken, E Holdener, H H Hansen, J Renard, M Rozencweig.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6744342

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  1 in total

1.  High dose AZQ in renal cancer. A Southwest Oncology Group phase II study.

Authors:  R L Stephens; R Kirby; E D Crawford; R Bukowski; S E Rivkin; R M O'Bryan
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.